Preliminary results from the first six patients taking part in a Phase One trial surprised and delighted the Oxford University team.
Although the trial was only designed to test safety and dosages, two men with relatively advanced disease experienced dramatic improvements to their eyesight.
The researchers are now planning a larger Phase II trial that will focus on the therapy's effectiveness.
More top news
Low pressure remaining in control gives more unsettled weather for the UK this weekend.
Charlie Gard, the baby boy whose fight for life captured the attention of the world has died, his family has confirmed.
A Royal Marine who lived a "dangerous double life" as a terrorist bomb-maker claims he faked Irish Republican sympathies out of fear.